StockMarketWire.com - Scancell Holdings, the developer of novel immunotherapies for the treatment of cancer, has confirmed that all resolutions proposed at the annual general meeting today were duly passed.


At 1:15pm: [LON:SCLP] Scancell Holdings PLC share price was -1.5p at 23.5p



Story provided by StockMarketWire.com